Jirí Vymetal

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The primary aim of this study was evaluation of the efficacy of telmisartan (angiotensin II receptor blocker- AT(1) blocker) on blood pressure in 10 patients with renal impairment in moderate or advanced stages of renal insufficiency and not dependent on haemodialysis. Its effect on proteinuria, renal function (represented by serum urea, creatinine,(More)
  • 1